AQR Capital Management
IRWD icon

AQR Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

AQR Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4M Buy
7,535,080
+2,811,549
+60% +$11.5M 0.01% 917
2025
Q4 		$15.9M Sell
4,723,531
-655,004
-12% -$1.7M 0.01% 1024
2025
Q3 		$7.05M Sell
5,378,535
-787,102
-13% -$815K ﹤0.01% 1259
2025
Q2 		$4.42M Buy
6,165,637
+3,641,762
+144% +$2.86M ﹤0.01% 1357
2025
Q1 		$3.71M Buy
2,523,875
+2,126,889
+536% +$5.07M ﹤0.01% 1273
2024
Q4 		$1.76M Sell
396,986
-167,127
-30% -$678K ﹤0.01% 1602
2024
Q3 		$2.32M Sell
564,113
-120,465
-18% -$648K ﹤0.01% 1431
2024
Q2 		$4.46M Buy
684,578
+214,836
+46% +$1.52M 0.01% 1073
2024
Q1 		$4.09M Buy
469,742
+387,941
+474% +$4.71M 0.01% 1066
2023
Q4 		$936K Sell
81,801
-121,768
-60% -$1.2M ﹤0.01% 1630
2023
Q3 		$1.96M Sell
203,569
-537,870
-73% -$5.27M ﹤0.01% 1332
2023
Q2 		$7.89M Buy
741,439
+60,737
+9% +$653K 0.02% 730
2023
Q1 		$7.16M Buy
680,702
+21,505
+3% +$241K 0.02% 760
2022
Q4 		$8.17M Buy
659,197
+82,809
+14% +$939K 0.02% 712
2022
Q3 		$5.97M Buy
576,388
+123,716
+27% +$1.4M 0.01% 791
2022
Q2 		$5.22M Buy
452,672
+481
+0.1% +$5.67K 0.01% 795
2022
Q1 		$5.69M Buy
452,191
+23,060
+5% +$264K 0.01% 824
2021
Q4 		$5M Buy
429,131
+91,766
+27% +$1.13M 0.01% 829
2021
Q3 		$4.41M Sell
337,365
-123,323
-27% -$1.59M 0.01% 839
2021
Q2 		$5.93M Sell
460,688
-79,785
-15% -$913K 0.01% 805
2021
Q1 		$6.04M Buy
540,473
+195,106
+56% +$2.06M 0.01% 792
2020
Q4 		$3.93M Buy
345,367
+60,652
+21% +$664K 0.01% 854
2020
Q3 		$2.56M Sell
284,715
-156,206
-35% -$1.55M ﹤0.01% 998
2020
Q2 		$4.55M Buy
440,921
+171,531
+64% +$1.76M 0.01% 823
2020
Q1 		$2.72M Buy
269,390
+122,277
+83% +$1.44M ﹤0.01% 979
2019
Q4 		$1.96M Buy
147,113
+94,870
+182% +$1.05M ﹤0.01% 1282
2019
Q3 		$449K Sell
52,243
-97,645
-65% -$949K ﹤0.01% 1789
2019
Q2 		$1.64M Buy
149,888
+86,404
+136% +$968K ﹤0.01% 1337
2019
Q1 		$719K Buy
+63,484
New +$709K ﹤0.01% 1672
2018
Q1 		– Sell
-15,986
Closed -$201K – 2251
2017
Q4 		$201K Sell
15,986
-16,847
-51% -$220K ﹤0.01% 2154
2017
Q3 		$434K Sell
32,833
-32,893
-50% -$453K ﹤0.01% 1987
2017
Q2 		$1.04M Hold
65,726
– – ﹤0.01% 1658
2017
Q1 		$939K Buy
65,726
+10,303
+19% +$141K ﹤0.01% 1701
2016
Q4 		$710K Buy
55,423
+7,253
+15% +$91.6K ﹤0.01% 1809
2016
Q3 		$641K Buy
+48,170
New +$563K ﹤0.01% 1869
2015
Q3 		– Sell
-29,060
Closed -$294K – 2214
2015
Q2 		$294K Sell
29,060
-32,312
-53% -$376K ﹤0.01% 1990
2015
Q1 		$822K Buy
61,372
+359
+0.6% +$4.71K ﹤0.01% 1502
2014
Q4 		$783K Sell
61,013
-12,896
-17% -$148K ﹤0.01% 1756
2014
Q3 		$802K Buy
+73,909
New +$846K ﹤0.01% 1727

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AQR Capital Management's IRWD Position: Q1 2026 in Review

AQR Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 60% in Q1 2026, buying an estimated $11.5M and bringing the position to 7,535,080 shares worth $26.4M. The position accounts for 0.01% of the portfolio, ranked #917.

AQR Capital Management first reported a position in IRWD in Q3 2014 and has held it in 39 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • AQR Capital Management held 7,535,080 shares of Ironwood Pharmaceuticals worth $26.4M as of Q1 2026.
  • AQR Capital Management bought 2,811,549 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $11.5M.
  • Ironwood Pharmaceuticals made up 0.01% of AQR Capital Management's portfolio in Q1 2026, its #917 holding.
  • AQR Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2014 and has held it in 39 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.